Patents by Inventor Andrija Lebar

Andrija Lebar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
    Publication number: 20200163882
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 28, 2020
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic
  • Hydrates of dolutegravir sodium
    Patent number: 10189860
    Abstract: The invention relates to novel hydrates of dolutegravir sodium and to processes for their preparation. Furthermore, the invention relates to a novel crystalline form of dolutegravir sodium, which is a useful intermediate for the preparation of one of the novel hydrates. In addition, the invention relates to the use of the novel hydrates for the production of pharmaceutical compositions. Finally, the invention relates to pharmaceutical compositions comprising an effective amount of the novel hydrates, to oral dosage forms comprising said pharmaceutical compositions, to a process for preparing said oral dosage forms, and to the use of said pharmaceutical compositions or dosage forms in the treatment of retroviral infections such as HIV-1 infections.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: January 29, 2019
    Inventors: Andreas Hotter, Andrea Thaler, Andrija Lebar, Biljana Jankovic, Klemen Naversnik, Uros Klancar, Zrinka Abramovic
  • Novel Hydrates Of Dolutegravir Sodium
    Publication number: 20170217987
    Abstract: The invention relates to novel hydrates of dolutegravir sodium and to processes for their preparation. Furthermore, the invention relates to a novel crystalline form of dolutegravir sodium, which is a useful intermediate for the preparation of one of the novel hydrates. In addition, the invention relates to the use of the novel hydrates for the production of pharmaceutical compositions. Finally, the invention relates to pharmaceutical compositions comprising an effective amount of the novel hydrates, to oral dosage forms comprising said pharmaceutical compositions, to a process for preparing said oral dosage forms, and to the use of said pharmaceutical compositions or dosage forms in the treatment of retroviral infections such as HIV-1 infections.
    Type: Application
    Filed: July 29, 2015
    Publication date: August 3, 2017
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Andreas Hotter, Andrea Thaler, Andrija Lebar, Biljana Jankovic, Klemen Naversnik, Uros Klancar, Zrinka Abramovic
  • Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
    Publication number: 20160346207
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: February 4, 2015
    Publication date: December 1, 2016
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic